The key event for the pharmaceutical industry, the 27th annual RUSSIAN PHARMACEUTICAL FORUM 2021 will take place on 12-13 May 2021 at our traditional venue, the Corinthia Hotel in SAINT PETERSBURG, as well as in  live ONLINE format. 
Join us at this meeting of the key international and Russian pharmaceutical industry experts! 

Meet new partners and network with the leading players on the pharmaceutical market – both in person in SAINT PETERSBURG (places strictly limited!), or via our online event platform, using live online chat, emails and video calls! 
If you are unable to join us in-person in St. Petersburg, you can connect to the event from your laptop, tablet or mobile phone – so you can save time travelling and maximise time learning from experts and engaging with speakers and other delegates. 

The Russian Pharma Forum is an annual meeting place, the main platform for active and productive dialogue between all the principal stakeholders in the Russian pharmaceutical market. What questions will be discussed in 2021? 
 
 
REGULATION OF THE SECTOR

• How has the pandemic affected the pharma regulatory landscape?
• Upcoming regulatory changes: what is important to know? 
   
   
  PRODUCTION
• Establishing new strategic partnerships with the leading international producers
• Production localisation and technology transfer of breakthrough drugs
• Development of active pharmaceutical substance production in Russia 
   
   
  DISTRIBUTION
• Evolution of the wholesale segment and pharmaceutical logistics
• Examples of new technologies in product distribution management
• Vertical integration – a new model of development for distribution businesses 
   
   
  RETAIL
• Development of the distance retail model for pharmaceutical products in Russia
• Challenges of implementing new methods of medical product delivery
• New kinds of competition and cooperation: pharma aggregators and marketplaces 
   
   
  TECHNOLOGY
• Integration of advanced production and research technologies and processes
• How to ensure consistent international quality standards  in drug manufacturing
• Big data in the pharmaceutical industry: from RWE to sales. Myths and reality 
   
   
  INNOVATION
• Development and market launch of new highly effective therapies in Russia
• Local research and development and products for treating complex diseases
• Lessons of COVID-19: breakthroughs in immunology, investment into vaccine development  
   
   
  PATIENTS
• How to make modern medical treatments highly accessible to patients?
• Paradigm shift – what is a socially responsible pharmaceutical business?
• What are the obstacles to successfully implementing a patient-oriented approach to healthcare? 
   
   
  HEALTHCARE
• Integrated solutions for the digital transformation of the healthcare system 
• Pharmaceutical industry and primary healthcare modernisation programme in Russia
• The role of pharmaceutical companies in expanding access to quality healthcare 
   
   
  SALES AND PROMOTION
• How to still survive and thrive when customer buying- power is reduced?
• What does an effective marketing strategy look like in the post-Covid era l?
• Market-leading case studies of digital visits by medical representatives 
   
  ANALYTICS
• Overview of the current state of the market and forecasts for future developments in Russia
• Which strategic directions should you prioritise and invest in today? 
  Competition on the Russian pharmaceutical market – leaders and new players 
  

Pharma versus coronavirus: interviews with General Directors 

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19. 

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products. 

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation. 

READ OUR PHRAMACEUTICAL BLOG>>